Skip to content

Tablet version of Kaletra receives European green light; MSF calls for fast registration in Africa

HIV/HCV coinfected patients have a poorer outcome after starting antiretrovirals than those who only have HIV

HIV Pharmacology Workshop: Are drug levels affected by racial differences?

HIV Pharmacology Workshop: The dangers of breaking up tablets for paediatric dosing

HIV Pharmacology Workshop: Explaining tenofovir renal toxicities and interactions with protease inhibitors

Terrence Higgins Trust closes specialist advice centre

HIV Pharmacology Workshop: Patch-testing to identify the genetic and clinical characteristics of abacavir hypersensitivity reaction - don’t try this at home

HIV Pharmacology Workshop: Explaining the genetic basis of AZT toxicity

Microbicides 2006: how will microbicides be delivered?

Microbicides 2006: what products are in the pipeline?

Study shows value of resistance testing before starting HIV treatment

Liver transplantation can be successful in patients co-infected with HIV and hepatitis B

First comprehensive HIV/STI management guidelines now available

US guidelines now recommend that all HIV-positive patients have a resistance test before starting HIV therapy

Treating HIV and TB at the same time does not compromise outcome for either infection

Does HIV therapy restore TB-specific immunity? Studies give conflicting answers

Current WHO treatment access criteria may have limited impact on onward transmission of HIV

Is diabetes a complication of HIV infection?